These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22317789)

  • 1. Development and validation of LC-MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study.
    Teijlingen Rv; Meijer J; Takusagawa S; Gelderen Mv; Beld Cv; Usui T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():102-11. PubMed ID: 22317789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of LC-MS/MS methods for the determination of mirabegron and eight metabolites in human plasma in a paediatric population.
    Meijer J; van den Berg T; Huls R; Hofstede V; Niesing W; van den Beld C; Krauwinkel W
    J Pharm Biomed Anal; 2019 Apr; 167():155-160. PubMed ID: 30776753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
    Takusagawa S; van Lier JJ; Suzuki K; Nagata M; Meijer J; Krauwinkel W; Schaddelee M; Sekiguchi M; Miyashita A; Iwatsubo T; van Gelderen M; Usui T
    Drug Metab Dispos; 2012 Apr; 40(4):815-24. PubMed ID: 22269146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
    J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in dog plasma and its application to a pharmacokinetic study.
    Zhang T; Sun Y; Zhang P; Gao J; Wang S; He Z
    Biomed Chromatogr; 2013 Feb; 27(2):137-41. PubMed ID: 22736298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a sensitive U-HPLC-MS/MS method with electrospray ionization for quantitation of ranolazine in human plasma: application to a clinical pharmacokinetic study.
    Tan QY; Zhu RH; Li HD; Fang PF; Yan M; Zhang QZ; Peng WX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():119-24. PubMed ID: 22749688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
    Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
    J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a rapid high-performance liquid chromatography-tandem mass spectrometry method for the determination of WJ-38, a novel aldose reductase inhibitor, in rat plasma and its application to a pharmacokinetic study.
    Lu J; Liu Y; Wang X; Wang S; Di X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():29-33. PubMed ID: 22425386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma.
    Wang Y; Chen X; Sun Z; Yang Y; Zhang Y; Liu W; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():10-6. PubMed ID: 22377406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Mirabegron in rat plasma by UPLC-MS/MS after oral and intravenous administration.
    Chen L; Zhang Y
    Rev Assoc Med Bras (1992); 2019 Feb; 65(2):141-148. PubMed ID: 30892436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid high-performance liquid chromatography-tandem mass spectrometry method for determination of pentoxifylline and its active metabolites M1 and M5 in human plasma and its application in bioavailability study.
    Vlase L; Kiss B; Muntean D; Leucuţa SE
    Talanta; 2010 Aug; 82(3):945-51. PubMed ID: 20678650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of buagafuran in human plasma by liquid chromatography-tandem mass spectrometry.
    Yang F; Wang H; Peng A; Liu M; Hu P; Jiang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(20):1789-94. PubMed ID: 21606008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of isotoosendanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetics study.
    Deng Z; Zhong H; Liu S; Cui S; Xie Y; Yao Q
    J Chromatogr Sci; 2013 Jan; 51(1):82-6. PubMed ID: 22815211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of tolperisone in human plasma by liquid chromatography/tandem mass spectrometry for clinical application.
    Choi CI; Park JI; Lee HI; Lee YJ; Jang CG; Bae JW; Lee SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():59-63. PubMed ID: 23217307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography/electrospray ionization tandem mass spectrometry for the quantification of mitiglinide in human plasma: validation and its application to pharmacokinetic studies.
    Zhang Y; Ding L; Tian Y; Yang J; Yang L; Wen A
    Biomed Chromatogr; 2008 Aug; 22(8):873-8. PubMed ID: 18318018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers.
    Shi A; Hu X; Li K; Li J; Han L; Wan H; Li R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():87-93. PubMed ID: 23122405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of bioanalytical methods for Imidafenacin (KRP-197/ONO-8025) and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
    Masuda Y; Kanayama N; Manita S; Ohmori S; Ooie T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):70-9. PubMed ID: 17387045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in human plasma.
    Wang H; Deng P; Chen X; Guo L; Zhong D
    Biomed Chromatogr; 2013 Jan; 27(1):34-8. PubMed ID: 22623034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.
    Koo TS; Kim SJ; Lee J; Ha DJ; Baek M; Moon H
    Biomed Chromatogr; 2011 Dec; 25(12):1389-94. PubMed ID: 21387355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.